All Stories

  1. Predictors of hemoglobin recovery or deferral in blood donors with an initial successful donation
  2. How safe is safe enough, who decides and how? From a zero‐risk paradigm to risk‐based decision making
  3. Data Mining to Improve Safety of Blood Donation Process
  4. Blood Donation: An Approach to Donor Vigilance
  5. In reply
  6. Predicting improvement in detection of bacteria in apheresis platelets by maintaining constant component sampling proportion
  7. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi
  8. Improving the performance of culture‐based bacterial screening by increasing the sample volume from 4 mL to 8 mL in aerobic culture bottles
  9. Is it time for new initiatives in the blood center and/or the hospital to reduce bacterial risk of platelets?
  10. Physiologic strategies to prevent fainting responses during or after whole blood donation
  11. The reintroduction of nonleukoreduced blood: would patients and clinicians agree?
  12. Interventions to reduce the vasovagal reaction rate in young whole blood donors
  13. BLOOD DONORS AND BLOOD COLLECTION: Delayed adverse reactions to blood donation
  14. West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual‐donation nucleic acid testing
  15. The impact of discontinuation of 7‐day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments
  16. Bacterial detection in apheresis platelets: blood systems experience with a two‐bottle and one‐bottle culture system
  17. Faint and prefaint reactions in whole‐blood donors: an analysis of predonation measurements and their predictive value
  18. Platelet bacterial contamination: assessing progress and identifying quandaries in a rapidly evolving field
  19. Safety and donor acceptance of an abbreviated donor history questionnaire
  20. Two‐year experience with aerobic culturing of apheresis and whole blood–derived platelets
  21. Screening the Blood Supply for West Nile Virus RNA by Nucleic Acid Amplification Testing
  22. Triggers for switching from minipool testing by nucleic acid technology to individual‐donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making
  23. Transfusion Alternatives: Impact on Blood Banking Worldwide
  24. Temporary iridium-192 implant in the management of carcinoma of the prostate
  25. Human T-Cell Lymphotropic Virus Infection among Blood Donors in South Florida
  26. Transmission of HIV‐1 by component type and duration of shelf storage before transfusion
  27. Screening of Selected Male Blood Donors for p24 Antigen of Human Immunodeficiency Virus Type 1
  28. Epidemiologic background of blood donors with antibody to human T‐cell lymphotropic virus
  29. Current autologous transfusion practices
  30. Automatic special case consultations in transfusion medicine
  31. KINETICS OF UNMATCHED AND HLA‐MATCHED RADIOACTIVELY‐LABELLED HOMOLOGOUS PLATELETS IN RECIPIENTS WITH CHRONIC MARROW HYPOPLASIA
  32. A plea for critical thought
  33. Interview
  34. A Study of Criteria for Blood Donor Deferral
  35. Congenital neutropenia: Studies of pathogenesis
  36. Preselection of donors to improve the quality of cryoprecipitate
  37. Multiple neoplasms in two siblings with a variant form of Fanconi's anemia
  38. Tritiation of endotoxin